DE3372483D1 - 1,3-dioxan-5-ylalkenoic acids - Google Patents

1,3-dioxan-5-ylalkenoic acids

Info

Publication number
DE3372483D1
DE3372483D1 DE8383302613T DE3372483T DE3372483D1 DE 3372483 D1 DE3372483 D1 DE 3372483D1 DE 8383302613 T DE8383302613 T DE 8383302613T DE 3372483 T DE3372483 T DE 3372483T DE 3372483 D1 DE3372483 D1 DE 3372483D1
Authority
DE
Germany
Prior art keywords
dioxan
ylalkenoic
acids
ylalkenoic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383302613T
Other languages
English (en)
Inventor
Andrew George Brewster
Peter William Rodney Caulkett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Application granted granted Critical
Publication of DE3372483D1 publication Critical patent/DE3372483D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/081,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
DE8383302613T 1982-05-12 1983-05-09 1,3-dioxan-5-ylalkenoic acids Expired DE3372483D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8213702 1982-05-12

Publications (1)

Publication Number Publication Date
DE3372483D1 true DE3372483D1 (de) 1987-08-20

Family

ID=10530304

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383302613T Expired DE3372483D1 (de) 1982-05-12 1983-05-09 1,3-dioxan-5-ylalkenoic acids

Country Status (32)

Country Link
US (3) US4567197A (de)
EP (1) EP0094239B1 (de)
JP (1) JPS58222081A (de)
KR (1) KR880002001B1 (de)
AR (1) AR240817A1 (de)
AT (1) ATE28329T1 (de)
AU (1) AU562056B2 (de)
CA (4) CA1258464A (de)
CS (2) CS245783B2 (de)
CY (1) CY1453A (de)
DD (2) DD219769A5 (de)
DE (1) DE3372483D1 (de)
DK (1) DK163431C (de)
ES (4) ES522331A0 (de)
FI (1) FI80027C (de)
GB (1) GB8310407D0 (de)
GR (1) GR78138B (de)
HK (1) HK17889A (de)
HU (1) HU198705B (de)
IE (1) IE55114B1 (de)
IL (1) IL68628A0 (de)
KE (1) KE3823A (de)
MW (1) MW1583A1 (de)
NO (1) NO162383B (de)
NZ (1) NZ204202A (de)
PH (1) PH21691A (de)
PL (3) PL140463B1 (de)
PT (1) PT76684B (de)
SG (1) SG57088G (de)
SU (1) SU1277893A3 (de)
ZA (1) ZA833179B (de)
ZW (1) ZW10083A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
FR2551446B1 (fr) * 1983-08-31 1987-03-20 Elf Aquitaine Compositions de resines ayant une resistance amelioree au choc renfermant un polymere thermoplastique, un additif choc du type copolymere greffe, et eventuellement d'autres additifs, et copolymere greffe correspondant, a caractere d'additif choc
GB8330097D0 (en) * 1983-11-11 1983-12-21 Ici Plc Cyclic ethers
GB8330094D0 (en) * 1983-11-11 1983-12-21 Ici Plc Diphenyl compounds
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8417314D0 (en) * 1984-07-06 1984-08-08 Ici Plc Carboxylic acid derivatives
GB8511897D0 (en) * 1985-05-10 1985-06-19 Ici Plc Carboxylic acids
GB8511894D0 (en) * 1985-05-10 1985-06-19 Ici Plc Phenol derivatives
DE3685775T2 (de) * 1985-05-10 1993-01-21 Ici Plc Alkenderivate.
GB8511891D0 (en) * 1985-05-10 1985-06-19 Ici Plc Alkenoic acids
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
HU198706B (en) * 1985-05-10 1989-11-28 Ici Plc Process for producing 1,3-dioxan-ethers and pharmaceutical compositions containing them
GB8511892D0 (en) * 1985-05-10 1985-06-19 Ici Plc Fluoralkane derivatives
GB8511895D0 (en) * 1985-05-10 1985-06-19 Ici Plc Heterocyclic compounds
GB8611174D0 (en) * 1986-05-08 1986-06-18 Ici Plc Amide derivatives
AU584763B2 (en) * 1985-11-12 1989-06-01 Imperial Chemical Industries Plc N-(6-(4-0-hydrxyphenyl-1,3-dioxan-cis-5-yl)hexenoyl) suphonamide derivatives
GB8531892D0 (en) * 1985-12-30 1986-02-05 Ici Plc Carboxylic acids
DE3603662A1 (de) * 1986-02-06 1987-08-13 Basf Ag Acetalisierte oder ketalisierte dihydroxyaldehyde, verfahren zu ihrer herstellung und diese enthaltende loesungen
GB8626296D0 (en) * 1986-11-04 1986-12-03 Ici Plc Therapeutic agents
GB8626297D0 (en) * 1986-11-04 1986-12-03 Ici Plc Pharmaceutical compositions
GB8709794D0 (en) * 1987-04-24 1987-05-28 Ici Plc Heterocyclic acids
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
EP0346511A1 (de) * 1988-06-15 1989-12-20 Fujisawa Pharmaceutical Co., Ltd. Sauerstoff enthaltende heterozyklische Verbindung, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
CN1034120C (zh) * 1988-10-21 1997-02-26 曾尼卡有限公司 制备二噁烷链烯酸衍生物的方法
IE81170B1 (en) * 1988-10-21 2000-05-31 Zeneca Ltd Pyridine derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
US5925795A (en) * 1996-09-16 1999-07-20 Zeneca Limited Processes for the preparation of aryl-β-diketones, arylpyrimidine ketones and crop protection intermediates
GB0413970D0 (en) * 2004-06-22 2004-07-28 Syngenta Participations Ag Chemical compounds
IN2015DN00502A (de) * 2006-01-18 2015-06-26 Evolva Sa
AU2008206048A1 (en) * 2007-01-18 2008-07-24 Evolva Sa Substituted 1,3-dioxanes and their uses
US20120142766A1 (en) * 2007-11-21 2012-06-07 Evolva Sa Substituted 1,3-dioxanes and their uses
AU2013261719B2 (en) * 2012-05-18 2017-07-27 Sanofi Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243592A (en) * 1979-03-12 1981-01-06 The Upjohn Company 9,11-Dideoxy-10-oxa-TXB compounds
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8417314D0 (en) * 1984-07-06 1984-08-08 Ici Plc Carboxylic acid derivatives

Also Published As

Publication number Publication date
ES8700249A1 (es) 1986-10-16
FI831664L (fi) 1983-11-13
AU562056B2 (en) 1987-05-28
DK211883A (da) 1983-11-13
PT76684A (en) 1983-06-01
MW1583A1 (en) 1985-02-13
ES8608507A1 (es) 1986-06-16
CA1269109A (en) 1990-05-15
PH21691A (en) 1988-01-13
PL140462B1 (en) 1987-04-30
SU1277893A3 (ru) 1986-12-15
FI80027B (fi) 1989-12-29
CS245795B2 (en) 1986-10-16
KR840004739A (ko) 1984-10-24
DD219769A5 (de) 1985-03-13
EP0094239B1 (de) 1987-07-15
CA1268771C (de) 1990-05-08
IE831005L (en) 1983-11-12
CS245783B2 (en) 1986-10-16
GR78138B (de) 1984-09-26
JPH0378389B2 (de) 1991-12-13
EP0094239A3 (en) 1984-12-12
AU1422383A (en) 1983-11-17
DK211883D0 (da) 1983-05-11
HK17889A (en) 1989-03-10
DK163431B (da) 1992-03-02
ES8407038A1 (es) 1984-08-16
PL140463B1 (en) 1987-04-30
GB8310407D0 (en) 1983-05-25
NZ204202A (en) 1986-05-09
ES528575A0 (es) 1986-10-16
EP0094239A2 (de) 1983-11-16
CS333683A2 (en) 1985-09-17
HU198705B (en) 1989-11-28
CY1453A (en) 1989-07-21
ZA833179B (en) 1984-04-25
ES8700250A1 (es) 1986-10-16
ES528577A0 (es) 1986-06-16
AR240817A2 (es) 1991-02-28
ES528576A0 (es) 1986-10-16
US4567197A (en) 1986-01-28
CA1268772A (en) 1990-05-08
CS725784A2 (en) 1985-09-17
PL250098A1 (en) 1985-07-02
ES522331A0 (es) 1984-08-16
NO831679L (no) 1983-11-14
FI831664A0 (fi) 1983-05-12
ATE28329T1 (de) 1987-08-15
SG57088G (en) 1989-01-27
KR880002001B1 (ko) 1988-10-11
PL250099A1 (en) 1985-07-02
JPS58222081A (ja) 1983-12-23
ZW10083A1 (en) 1984-11-28
AR240817A1 (es) 1991-02-28
CA1258464A (en) 1989-08-15
FI80027C (fi) 1990-04-10
PL241920A1 (en) 1985-03-26
IL68628A0 (en) 1984-05-31
IE55114B1 (en) 1990-06-06
DK163431C (da) 1992-07-20
DD212515A5 (de) 1984-08-15
PT76684B (en) 1986-01-14
US5166377A (en) 1992-11-24
KE3823A (en) 1988-10-21
CA1268771A (en) 1990-05-08
NO162383B (no) 1989-09-11
US4745198A (en) 1988-05-17
PL140274B1 (en) 1987-04-30

Similar Documents

Publication Publication Date Title
DE3372483D1 (de) 1,3-dioxan-5-ylalkenoic acids
ES532380A0 (es) Acidos 7-amino-1-ciclopropil-6,8-difluor-1,4-dihidro-4-oxo-quinolincarboxilicos
MA19680A1 (fr) N- arylsulfonyl - n' - pyrimidinylurees.
DK587183D0 (da) 1,4-benzodiazepin-derivater
FI833229A0 (fi) 20-aminomakrolidderivat
DE3371781D1 (de) 1,4-methano-2-benzazepine derivatives
MX9203211A (es) 6'-alquilespectinomicinas.
DE3365097D1 (de) 6,7-dihydro-7,7-disubstituted-khellins
IT8349567A0 (it) 2,2,2-trialogeno-1-(trialogenometiletiliden-bis-benzen-tioli
DE3369969D1 (de) Alpha, omega-perfluorodicarboxylic acids
DE3360666D1 (de) 2,6-dicyanoanilines
FI834384A (fi) Framstaellningsfoerfarande foer 4(5)- acetyl-2-metylimidazol.
ES267636Y (es) "lustrador".
ES264864Y (es) "pesacartas".
DE3363710D1 (de) 1,3,5-triacrylylhexahydro-s-triazine derivatives
ES266719Y (es) "muneco perfeccionado".
ATE20343T1 (de) 2-amino-6-biphenylessigsaeuren.
IT8248345A0 (it) Eliocell 101
ES265530Y (es) "perfil-esquinero perfeccionado".
ES267940Y (es) "bolsa-nevera".
ES267947Y (es) "cortapelo".
ES267859Y (es) "limpiapeines".
ES265809Y (es) "contenedor-expositor".
ES265226Y (es) "tapapezunas".
ES264963Y (es) "cartera-estera".

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee